Prevalence of comorbidities and management of gout in a tropical city in Australia
详细信息 查看全文
- 作者：Andrew Jeyaruban ; Muriel Soden ; Sarah Larkins
- 关键词：Gout ; Allopurinol ; General practice ; Family medicine ; Gouty arthritis
- 刊名：Rheumatology International
- 出版年：2016
- 出版时间：December 2016
- 年：2016
- 卷：36
- 期：12
- 页码：1753-1758
- 全文大小：411 KB
- 刊物主题：Rheumatology;
- 出版者：Springer Berlin Heidelberg
- ISSN：1437-160X
- 卷排序：36
文摘
To examine the management of gout in general practice in Townsville, Australia, and to explore comorbid conditions in patients with gout. Study will also explore how closely guidelines are being followed in managing gout. Retrospective chart review was conducted from May to November 2014 in three general practices in Townsville. Registers for patients were established by searching “gout” and “gouty arthritis”. Three hundred and twenty-one patients were included in the study after excluding inactive patients, patients below age of 18 and patients with cancer. Main outcome measures were prevalence of comorbidities in gout patients, gout medications and adequate serum urate control (≤0.36 mmol/l). Multivariate logistic regression was used to study the relationship between serum urate level, comorbid conditions and lifestyle factors. Hypertension was the most common comorbid condition with 60.8 % of patients followed by obesity and dyslipidaemia. In terms of medication, 46.7 % of patients were on allopurinol, 12.8 % on indomethacin and 13.4 % on diuretics. Eighty-six percentage of patients had serum urate level (sUA) recorded in the previous year. Of these, 32.2 % had a serum urate level below or equal to 0.36 mmol/l. Moreover, 17.4 % of patients had lifestyle advice documented in chart. Male gender was the most influential factor in having poor uric acid control (p < 0.01), followed by not being on allopurinol (p < 0.01) and patients older than 50 years (p = 0.02). Management of gout in this study sample was not entirely concordant with guidelines. The study also suggests a need for possible tighter monitoring and allopurinol dosing regime in older, male patients.